Robotic-assisted surgery as an enabling technology for ovarian-sparing management in pediatric benign ovarian tumours: a comparative study - Summary - MDSpire
Advertisement
Robotic-assisted surgery as an enabling technology for ovarian-sparing management in pediatric benign ovarian tumours: a comparative study
To evaluate the feasibility and perioperative safety of robotic-assisted ovarian-sparing surgery and to compare outcomes with a pre-robotic cohort.
Approach:
Key Findings:
Ovarian-sparing surgery was achieved in all robotic cases (100%) compared to 85.7% in the pre-robotic cohort.
No conversions to open surgery occurred in the robotic group; two conversions/oophorectomies occurred in the pre-robotic cohort.
Operative time was longer in the robotic cohort (median 2:27:30 vs. 1:42:00; p=0.021).
Length of hospital stay remained comparable between cohorts.
One robotic patient required reoperation for trocar-site bleeding.
Opioid rescue therapy was significantly less frequent in the robotic cohort (10% vs. 50%; p=0.048).
Interpretation:
Robotic-assisted ovarian-sparing surgery for benign ovarian tumours in pediatric and adolescent patients is feasible and safe, facilitating precise tumour enucleation and preservation of healthy ovarian tissue.
Limitations:
The study is retrospective and conducted at a single centre, which may limit generalizability.
The sample size is small, with only 24 patients included.
Conclusion:
Robotic-assisted surgery may enhance ovarian-sparing management in pediatric patients with benign ovarian tumours.
by M. M. Cantagalli, Marco Di Mitri, Antonino Morabito, A. Brucculeri, S. Muscolino, E. Severi, E. Bencini, F. Fierro, Enrico Ciardini, Riccardo Coletta
Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.